Pharmacogenomics of Mood Disorder in Chronic Kidney Disease Patients
NCT ID: NCT06675396
Last Updated: 2024-11-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
300 participants
OBSERVATIONAL
2024-12-01
2028-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pharmacogenomics on Individualized Precise Treatment of Patients with Depression
NCT05669391
Systematic Genetic Analysis of Phenomenology and Treatment Response in Mood Disorders
NCT01769859
Clinical Validation of a Combinatorial Pharmacogenomic Approach in Major Depressive Disorder
NCT04615234
Cognitive Behavioral Treatment of Depression in ESRD Patients on Dialysis
NCT00618475
Depression, Genes, Cytokines, Chronic Fatigue, Physical Illnesses and Quality of Life
NCT02943330
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
chronic kidney with mood disorder
Patients developed mood disorder after chronic kidney disease development
Antidepressants
control
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Antidepressants
control
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wonju Severance Christian Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jun Young Lee
Professor
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CKD Research Institute
Identifier Type: OTHER
Identifier Source: secondary_id
CKD gene
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.